A review of age-old antimalarial drug to combat malaria:efficacy upgradation by nanotechnology based

• 作 者: Satyajit Tripathy Somenath Roy
• 机 构: Immunology and Microbiology Laboratory,Department of Human Physiology with Community Health,Vidyasag
• 出 处: Asian Pacific Journal of Tropical Medicine
• 发表日期: 2014年09期
• 关键词: nanotechnology pharmaceutical practically parasite burden conduct instability co

Malaria is uncontrolled burden in the world till now.Despite of different efforts to develop antimalarial drug for decades,any anti-malarial drug can able to eradicate completely till now.Many anti-malarial substances are practically ineffectual because of their physicochemical limitations,cytotoxicity,chemical instability and degradation,and limited activities against intracellular parasites.Taking into consideration,the amount of research is going to conduct in the field of nanoparticle based drug delivery systems,lead to new ways of improving the treatment of infectious diseases.The study has focused on the progress and advancement of research on nanotechnology based drug delivery to eradicate the malaria.We like to focus the efficacy of nanotechnology based drug application for the opening out of novel chemotherapeutics in laboratory research,which may show the way to better use with age-old antimalarial drug and may draw the attention of pharmaceutical industries for the improvement and designing of effective anti-malarial drugs in future.

Malaria is uncontrolled burden in the world till now.Despite the different efforts to develop antimalarial drug for decades, any anti-malarial drug can to eradicate completely till now. Many anti-malarial substances are practically ineffectual because of their physicochemical limitations, cytotoxicity, chemical instability and degradation, and limited activities against intracellular parasites. Taking into consideration, the amount of research is going to conduct in the field of nanoparticle based drug delivery systems, lead to new ways of improving the treatment of infectious diseases. The study has focused on the progress and advancement of research on nanotechnology based drug delivery to eradicate the malaria. We like to focus the efficacy of nanotechnology based drug application for the opening out of novel chemotherapeutics in laboratory research, which may show the way to better use with age- old antimalarial drug and may draw the attention of pharmaceutical industries for the improveme nt and designing of effective anti-malarial drugs in future.